Kontoor Brands, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Kontoor Brands, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,830	2,764	2,549	2,098	2,476	2,631	2,607	2,608	3,152
Cost of revenue	1,658	1,649	1,544	1,234	1,368	1,497	1,520	1,446	1,729
Gross profit	1,172	1,115	1,004	864	1,108	1,134	1,088	1,162	1,423
Selling, general and administrative	815	782	803	740	825	778	769	819	1,087
Operating income	357	333	168	124	283	357	319	342	337
Interest expense	1.26	1.17	35.8	50	38.9	34.9	40.4	40.8	62.2
Interest income	2.98	5.74	3.93	1.61	1.48	1.35	3.79	11.1	7.3
Other non-operating income	-3.36	-5.27	-5	-2.51	-0.96	-3.96	-10.8	-11.2	11.3
Pre-tax income	359	340	135	72.9	245	319	272	301	293
Income tax	243	77	38.5	5.01	49.2	73.6	40.9	55.6	71.2
Net income	116	263	96.7	67.9	195	245	231	246	227
EBITDA	391	364	199	158	320	394	357	385	385
EPS, basic	2.05	4.64	1.71	1.19	3.40	4.40	4.13	4.42	4.10
EPS, diluted	2.05	4.64	1.69	1.17	3.31	4.31	4.06	4.36	4.05
Shares, basic (weighted)	56.6	56.6	56.7	57	57.4	55.7	56	55.5	55.5
Shares, diluted (weighted)	56.6	56.6	57.2	57.9	59.1	57	56.9	56.3	56.1
Dividend per share		0.00	1.12	0.96	1.66	1.86	1.94	2.02	2.09

Balance sheet

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	80.8	96.8	107	248	185	59.2	215	334	77.2
Receivables		253	228	231	290	226	218	244	209
Inventory		474	458	341	363	597	500	390	436
Other current assets		52	84.2	81.4	72.6	100	111	96.3	102
Total current assets		1,941	878	902	911	982	1,044	1,064	1,081
Property, plant and equipment	132	138	132	119	105	104	112	103	113
Lease right-of-use assets		0	86.6	60.4	55	51	54.8	47.2	110
Goodwill	219	215	213	213	212	210	210	209	451
Intangible assets		53.1	17.3	16	14.6	13.4	12.5	11.2	446
Other non-current assets		67.7	111	150	161	154	137	140	212
Total assets		2,458	1,517	1,546	1,533	1,582	1,645	1,651	2,583
Accounts payable		134	147	167	214	206	180	180	196
Accrued liabilities		194	195	193	217	197	171	193	238
Deferred revenue		2.31	1.78	0.79	2.26	1.06	1.71	1.76	1.95
Short-term debt		0	0	25	0	10	20	0	8.75
Total current liabilities		617	379	414	456	440	393	394	594
Long-term debt		0	913	888	791	783	764	740	1,135
Lease liabilities		0	54.7	39.8	33	31.5	36.8	30	95.4
Other non-current liabilities		116	98.9	115	99.2	70	74.6	80.6	164
Total liabilities		735	1,448	1,461	1,385	1,332	1,274	1,250	2,018
Total debt		0	913	913	791	793	784	740	1,143
Paid-in capital		0	151	172	218	244	273	317	358
Retained earnings		0	-1.72	7.15	22.6	86.7	167	200	274
Other comprehensive income	-122	-145	-79.7	-94.8	-92.8	-79.7	-67.9	-117	-67.5
Shareholders' equity	1,358	1,723	69.3	84.6	148	251	372	400	565
Total equity	1,358	1,723	69.3	84.6	148	251	372	400	565
Total liabilities and equity		2,458	1,517	1,546	1,533	1,582	1,645	1,651	2,583
Shares outstanding		0	56.8	57.3	56.4	55.5	55.7	55.3	55.2

Cash flow statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	116	263	96.7	67.9	195	245	231	246	227
Depreciation and amortization	33.6	31	30.8	34.5	36.6	37.1	38	42.6	47.8
Stock-based compensation	13	14.9	23.8	15.9	38.5	21.9	16.7	26.6	39.1
Deferred income tax	36.5	2.53	-4.17	2.71	3.64	0.13	-3.75	-6.71	29.6
Change in receivables	-36.4	-17.7	25	-17.6	-61	56.7	14.9	-35.4	56.2
Change in inventory	22.1	-45.8	9.68	119	-24.9	-236	101	103	4.5
Cash from operations	169	-96.3	778	242	284	83.6	357	368	456
Capital expenditures	-25.6	-21	-22.7	-18.2	-10.6	-18.4	-27.4	-18.8	-21
Acquisitions							0	0	-901
Cash from investing	-57.6	11.3	484	-49.1	-39.4	-30.1	-39.1	-22.3	-899
Debt issued	0	0	1,050	0	400	0	0
Debt repaid	0	0	-127	0
Stock issued		0	1.04	1.39	-1.95	-11.7	0.28	2.38	-9.68
Share buybacks			0	0	-75.5	-62.5	-30.1	-85.7	-25
Dividends paid	0	0	-63.6	-54.8	-95.1	-104	-109	-112	-116
Cash from financing	-120	106	-1,252	-57.7	-304	-171	-156	-240	247
Exchange rate effect	2.8	-5.39	0.39	6.11	-3.24	-8.7	-5.84	13.4	-29.5
Net change in cash	-6.04	16	10	141	-62.8	-126	156	119	-226
Free cash flow	143	-117	755	224	273	65.2	329	349	435
Interest paid	6.46	6.62	29.4	47.1	27.1	32	36.4	40.7	59.5
Income taxes paid	1.72	0.18	28.9	15.6	32.6	67.8	74.2	53.4	67.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $65.37 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	53.8%	Gross profit / revenue.
Operating margin	12.5%	Operating income / revenue.
EBITDA margin	14.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.3%	Pre-tax income / revenue.
Net margin	7.8%	Net income / revenue.
FCF margin	12.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.0%	Cash from operations / revenue.
Effective tax rate	24.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	43.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.1%	Net income / average total assets.
Return on invested capital (ROIC)	19.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	32.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	20.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	22.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-1.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-1.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	22.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	19.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-7.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-2.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	27.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-7.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-2.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	28.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	23.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	76.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	24.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	88.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	14.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	4.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	16.8%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	41.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	31.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	46.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	56.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	17.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.83x	Current assets / current liabilities.
Quick ratio	0.45x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.09x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.85x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	42.9%	Total debt / total assets.
Liabilities / assets	76.8%	Total liabilities / total assets.
Net debt	$1.09B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.08x	Operating income / interest expense.
Working capital	$521.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	34.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$290.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.29x	Revenue / average total assets.
Fixed asset turnover	31.0x	Revenue / average property, plant and equipment.
Inventory turnover	3.02x	Cost of revenue / average inventory.
Days inventory	121 days	365 x average inventory / cost of revenue.
Receivables turnover	15.6x	Revenue / average receivables.
Days sales outstanding	23 days	365 x average receivables / revenue.
Days payables	58 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	86 days	Days inventory + days sales outstanding - days payables.
FCF conversion	157.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	5.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.83	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$61.89	Revenue / diluted weighted shares.
FCF per share	$7.61	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.04	Cash from operations / diluted weighted shares.
Book value per share	$11.32	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.31	Tangible book value / shares outstanding.
Cash per share	$1.07	(Cash + short-term investments) / shares outstanding.
Payout ratio	43.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	27.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	23.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.57B	Share price x shares outstanding.
Enterprise value	$4.66B	Market cap + total debt - cash - short-term investments.
P/E	13.3x	Market cap / net income. Only when net income is positive.
P/S	1.04x	Market cap / revenue.
P/B	5.78x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	8.46x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.01x	Market cap / cash from operations, when positive.
EV/Sales	1.36x	Enterprise value / revenue.
EV/EBIT	10.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.61x	Enterprise value / EBITDA, when both are positive.
EV/FCF	11.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.8%	Free cash flow / market cap.
Earnings yield	7.5%	Net income / market cap (the inverse of P/E).
Dividend yield	3.3%	Dividends paid over the period / market cap.
Shareholder yield	6.1%	(Dividends paid + share buybacks) / market cap.

What was Kontoor Brands, Inc.'s revenue in fiscal 2025?

Kontoor Brands, Inc. reported revenue of $3.15B for fiscal 2025, 20.9% higher than the year before.

Was Kontoor Brands, Inc. profitable in fiscal 2025?

Yes. Net income was $227.5M, a net margin of 7.2%.

How much free cash flow did Kontoor Brands, Inc. generate in fiscal 2025?

Cash from operations of $455.8M minus capital expenditures of $21.0M left free cash flow of $434.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Kontoor Brands, Inc.